At ProPepMD, our mission is to provide clinically grounded educational content regarding investigational compounds under scientific evaluation for their relationship to sleep physiology, including DSIP (Delta Sleep-Inducing Peptide), Sermorelin, and Epithalon
A dermatologist evaluation is essential
The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
You should also report signs of pregnancy while on tirzepatide, as the medication's effects on gastrointestinal absorption could theoretically impact oral contraceptive efficacy
